{
    "nct_id": "NCT04708860",
    "official_title": "Pilot Study of the Impact of a Combined Intermittent Fasting and Exercise Intervention on Metabolic Markers in Patients With Advanced, Hormone Receptor Positive Breast Cancer",
    "inclusion_criteria": "* Diagnosis of ER and/or PR+ metastatic or locally unresectable breast cancer\n* Postmenopausal (including concurrent use of ovarian suppression)\n* Initiating endocrine therapy in combination with:\n\n  * Cohort 1: alpelisib\n  * Cohort 2: palbociclib\n* Self-reported ability to walk two blocks\n* > 18 years of age\n* Approval from treating oncologist, confirmed via email or in writing\n* Ability to read and understand English\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Diagnosis of diabetes requiring medication\n* Engaging in >90 minutes of moderate or vigorous physical activity per week",
    "miscellaneous_criteria": ""
}